{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:54:59Z","timestamp":1791273299123,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"Division of Intramural Research of NIAID, Division of Clinical Research, NIAID, IRF; and Battelle Memorial Institute\u2019s (BMI) prime contract with NIAID","award":["HHSN272200700016I"],"award-info":[{"award-number":["HHSN272200700016I"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194880","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T13:50:27Z","timestamp":1521726627000},"page":"e0194880","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs"],"prefix":"10.1371","volume":"13","author":[{"given":"Elena","family":"Postnikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5037-0729","authenticated-orcid":true,"given":"Yu","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Evans","family":"DeWald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dyall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit J.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Logue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Deiuliis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Michelotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna N.","family":"Honko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene G.","family":"Olinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Jahrling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"issue":"5656","key":"ref1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1092528","article-title":"Multiple Ebola virus transmission events and rapid decline of central African wildlife","volume":"303","author":"EM Leroy","year":"2004","journal-title":"Science"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nri1154","article-title":"Ebola virus: from discovery to vaccine","volume":"3","author":"H Feldmann","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"12 Suppl","key":"ref3","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"TW Geisbert","year":"2004","journal-title":"Nat Med"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria","volume":"73","author":"EM Malkin","year":"2005","journal-title":"Infect Immun"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.1999.tb08038.x","article-title":"The Soviet Union's anti-agricultural biological weapons","volume":"894","author":"K Alibek","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"18","key":"ref6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"L Borio","year":"2002","journal-title":"JAMA"},{"issue":"8991\u20138992","key":"ref7","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0140-6736(95)92841-3","article-title":"Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory","volume":"346","author":"N Jaax","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"ref8","first-page":"227","article-title":"Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus","volume":"76","author":"E Johnson","year":"1995","journal-title":"Int J Exp Pathol"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"TT Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/phar.1545","article-title":"Treatment of ebola virus disease","volume":"35","author":"PE Kilgore","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"123","key":"ref11","doi-asserted-by":"crossref","first-page":"123ra24","DOI":"10.1126\/scitranslmed.3003500","article-title":"Productive replication of Ebola virus is regulated by the c-Abl1 tyrosine kinase","volume":"4","author":"M Garcia","year":"2012","journal-title":"Science translational medicine"},{"issue":"190","key":"ref12","doi-asserted-by":"crossref","first-page":"190ra79","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection","volume":"5","author":"LM Johansen","year":"2013","journal-title":"Sci Transl Med"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"e60579","DOI":"10.1371\/journal.pone.0060579","article-title":"A systematic screen of FDA-approved drugs for inhibitors of biological threat agents","volume":"8","author":"PB Madrid","year":"2013","journal-title":"PloS one"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/acsinfecdis.5b00089","article-title":"Screening of FDA-Approved Drugs for Treatment of Emerging Pathogens","volume":"1","author":"JM Sisk","year":"2015","journal-title":"ACS Infect Dis"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.13.4.791-793.1981","article-title":"Plaque assay for Ebola virus","volume":"13","author":"JB Moe","year":"1981","journal-title":"J Clin Microbiol"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1128\/JCM.40.7.2323-2330.2002","article-title":"Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR","volume":"40","author":"C Drosten","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.antiviral.2009.03.008","article-title":"Identification of bisindolylmaleimides and indolocarbazoles as inhibitors of HCV replication by tube-capture-RT-PCR","volume":"83","author":"Y Murakami","year":"2009","journal-title":"Antiviral research"},{"issue":"Suppl 2","key":"ref18","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1086\/520601","article-title":"High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings","volume":"196","author":"JS Towner","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.10.048","article-title":"Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening","volume":"332","author":"JS Towner","year":"2005","journal-title":"Virology"},{"issue":"Suppl 2","key":"ref20","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1093\/infdis\/jiv223","article-title":"Novel Small Molecule Entry Inhibitors of Ebola Virus","volume":"212","author":"A Basu","year":"2015","journal-title":"J Infect Dis"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1128\/JVI.03050-13","article-title":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay","volume":"88","author":"HA Elshabrawy","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2011.10.011","article-title":"Identification of an antioxidant small-molecule with broad-spectrum antiviral activity","volume":"93","author":"RG Panchal","year":"2012","journal-title":"Antiviral research"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1128\/JVI.01456-10","article-title":"Identification of a small-molecule entry inhibitor for filoviruses","volume":"85","author":"A Basu","year":"2011","journal-title":"J Virol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clbc.2013.10.014","article-title":"Toremifene for breast cancer: a review of 20 years of data","volume":"14","author":"CL Vogel","year":"2014","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"ref25","first-page":"749","article-title":"Phase II clinical trial of high-dose toremifene as primary hormone therapy in aromatase inhibitor-resistant breast cancer","volume":"40","author":"H Ogata","year":"2013","journal-title":"Gan To Kagaku Ryoho"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1188\/04.CJON.529-530","article-title":"Toremifene citrate (Fareston)","volume":"8","author":"P Gerken","year":"2004","journal-title":"Clin J Oncol Nurs"},{"issue":"14","key":"ref27","first-page":"2363","article-title":"Phase I study of NK 622 (toremifene citrate)","volume":"19","author":"T Tominaga","year":"1992","journal-title":"Gan To Kagaku Ryoho"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"e0166318","DOI":"10.1371\/journal.pone.0166318","article-title":"Evaluation of the activity of lamivudine and zidovudine against Ebola virus","volume":"11","author":"Y Cong","year":"2016","journal-title":"PloS one"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"e0004709","DOI":"10.1371\/journal.pntd.0004709","article-title":"Characterization of yellow fever virus Infection of human and non-human primate antigen presenting cells and their interaction with CD4+ T cells","volume":"10","author":"Y Cong","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref30","first-page":"298","article-title":"Pathology of experimental Ebola-Zaire (Mayinga) virus infection transmitted to guinea pigs by oral, conjunctival and tonsillar routes","volume":"4","author":"P Vogel","year":"1997","journal-title":"Cell Vision"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nchembio.2007.17","article-title":"High-throughput screening assays for the identification of chemical probes","volume":"3","author":"J Inglese","year":"2007","journal-title":"Nat Chem Biol"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"JH Zhang","year":"1999","journal-title":"J Biomol Screen"},{"issue":"290","key":"ref33","doi-asserted-by":"crossref","first-page":"290ra89","DOI":"10.1126\/scitranslmed.aaa5597","article-title":"A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity","volume":"7","author":"LM Johansen","year":"2015","journal-title":"Sci Transl Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.foodchem.2013.10.024","article-title":"Determination of residual enrofloxacin in food samples by a sensitive method of chemiluminescence enzyme immunoassay","volume":"149","author":"F Yu","year":"2014","journal-title":"Food Chem"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.saa.2011.06.047","article-title":"Chemiluminescence enzyme immunoassay for the determination of sulfamethoxydiazine","volume":"81","author":"Y Wu","year":"2011","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1087057110374357","article-title":"Development of high-content imaging assays for lethal viral pathogens","volume":"15","author":"RG Panchal","year":"2010","journal-title":"J Biomol Screen"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/187152609787847730","article-title":"Drug targets in infections with Ebola and Marburg viruses","volume":"9","author":"GG Olinger","year":"2009","journal-title":"Infect Disord Drug Targets"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/154065804322966315","article-title":"Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays","volume":"2","author":"TL Riss","year":"2004","journal-title":"Assay Drug Dev Technol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-61779-108-6_12","article-title":"Cytotoxicity testing: measuring viable cells, dead cells, and detecting mechanism of cell death","volume":"740","author":"TL Riss","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"18","key":"ref40","doi-asserted-by":"crossref","first-page":"15854","DOI":"10.1074\/jbc.M110.207084","article-title":"Inhibition of Ebola virus entry by a C-peptide targeted to endosomes","volume":"286","author":"EH Miller","year":"2011","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.antiviral.2015.10.010","article-title":"The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus","volume":"125","author":"LK McMullan","year":"2016","journal-title":"Antiviral research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T20:07:26Z","timestamp":1604002046000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194880"}},"subtitle":[],"editor":[{"given":"Alexander N","family":"Freiberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194880","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]}}}